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ABSTRACT
Synthesis of Ester Derivatives of Resveratrol as Potential Anti-Cancer Drugs
by
Parasmani Pageni

Resveratrol is a naturally occurring phytoalexin of the stilbene family produced by various plants
in response to stress, UV radiation, and fungal attack. It is primarily found in peanuts, berries,
grape skin, and red wine. Resveratrol has been found to exhibit anti-cancer, anti-inflammatory,
anti-aging, and anti-oxidant properties. Research indicates that diets enriched with resveratrol
containing substances result in less incidence of cancer. Unfortunately, the low bioavailability
and solubility has been a huge setback for its potential prospects. As a result, efforts have been
made to synthesize derivatives of resveratrol with increased solubility and bioavailability. Three
triester novel resveratrol derivatives 3, 4’, 5-tri (benzoyloxy) stilbene, 3, 4’, 5-tri (toluyloxy)
stilbene and 3, 4’, 5-tri (2”-butenoyloxy) stilbene have been synthesized by esterification process
that can further be subjected for biological evaluation. Structures and purities of all newly
synthesized derivatives were confirmed by 1H, 13C NMR spectroscopy and infrared
spectroscopy.
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CHAPTER 1
INTRODUCTION
With the advent of science and technology, there has been vast improvement in the field
of health science. Medical conditions that were considered fatal and untreatable are no more
threat for mankind. Just in US alone the average expectancy age has increased from 50 at early
1900s to almost 80 in 20001. This improvement is only possible with the discovery of new drugs
and better medical facilities. A lot of these drugs actually have been discovered from the plant
and natural sources after a long research2. Among the compounds with a discovery origin to
plants is resveratrol (RV). Resveratrol is a natural polyphenol that is primarily found in berries,
peanuts, grape skin, and red wine. It is also a phytoalexin produced by plants in response to
stress, injury, fungal attack, and UV radiation. It has been into media attention lately for its
various health benefits. It has been found to exhibit anti-inflammatory, anti-cancer, anti-oxidant,
anti-aging, antiobesity, and neuroprotective properties. As a phytoestrogen, it can provide
cardiovascular protection. Its uses have also been linked with the metabolism of lipids, oxidation
of low-density lipoproteins and aggregation of platelets 3. Resveratrol was found to inhibit the
initiation, promotion and progression stages of cancer displaying the chemo preventive effects 4.
Currently, resveratrol is in clinical phase II trials as anti-cancer drug for human colon cancer 5.
In vivo experiments conducted in rodents show evidence of positive effects in controlling stress
and disease in rodent models 6. However, the solubility and bioavailability of resveratrol is very
low so higher concentrations should be administered to see any therapeutic effects in the body.
To overcome the setback, efforts have been made to synthesize water soluble derivative. The
new derivative with new increased solubility and bioavailability will be promising tools as
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cancer chemo preventive agents, as well as cancer therapeutics in the prevention and treatment of
cancer.
Cancer
Cancer is the second leading cause of deaths in western countries after heart disease. In
US alone more than one million people are diagnosed with cancer annually and more than half
result in death. Cancer is a medical condition where abnormal cells in body divide without any
control. Cancer cells do not respond normally to the body’s control mechanism, so they divide
excessively and invade the neighboring tissues. If cancer cells are provided with the nutrition
they need, they can divide indefinitely. An experiment was done to prove the immortality of
cancer cell. HeLa cells, cancer cells taken from a woman named Henrietta Lacks, have been
reproducing in culture since 19516. Cancer starts when a normal cell in the body converts to a
cancer cell through the process of transformation. A transformed cell is instantly detected by
body’s immune system. However, if it manages to evade, it may proliferate and form a mass of
abnormal cells called tumor. If the abnormal cells remain at the original site, it will result in the
less severe condition termed as benign tumor. Benign tumor can be completely removed by
surgery and pose little threat. Malignant tumors have capability to enter the bloodstream
invading other tissues and disrupting the normal function of various systems in the body. They
are difficult to treat and may become life threatening. Cancer cells can spread to distant locations
from the original site by a process called metastasis.
Types of Cancer
Cancers are named according to the type of tissue in which cancer originates i.e.
histological type and contains suffix to represent the site6-8. Below are the five broad groups to
classify the cancer.
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1. Carcinomas consist of the cancer that originates at the cells that cover internal and
external parts of body. It can further be divided into two major subtypes:
adenocarcinoma, which develops in an organ or gland, and squamous cell carcinoma,
which originates in the squamous epithelium. Most carcinomas affect organs or glands
capable of secretion, such as the breasts, which produce milk, or the lungs, which secrete
mucus, or colon or prostate or bladder.
2. Sarcoma refers to cancer that originates in supportive and connective tissues such as
bones, tendons, cartilage, muscle, and fat. The most common sarcoma usually invades the
bone creating a massive pain.
3. Lymphomas are cancers that initiate in the immune system tissues like lymph nodes.
4. Leukemias are cancers that begin in the bone marrow and often accumulate in the blood
stream.
5. Adenomas are the cancers that arise in the glandular tissues. Cancer in glands like
thyroid, pituitary, and adrenal falls into this category.
Causes of Cancer
Normal cells in the body follow a path of growth, division, and death. After a certain
number of divisions a cell is programmed to die called apoptosis, and when the cell ceases to die
cancer begins to form. Cancer cells do not experience programmatic death and instead continue
to divide. This abnormal behavior of cells is the result of mutation in regulatory genes. Genes are
the instructions that tell cells what to do and are made up of DNA. So, the cancer occurs when
there are changes in the DNA of a cell. These changes may be either inherited genetically from
parents or caused by environmental factors. The various factors that can cause the damage on
DNA to lead cancer are listed below.
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▪ Carcinogens: Any substance that is capable of developing cancer is known as a carcinogen. The
carcinogen changes the structure of DNA resulting in a mutation that finally leads to cancer.
Commonly known carcinogens include asbestos, arsenic, benzene, bisphenolA (BPA), pesticides,
dioxins, UV radiation, polybrominateddiphenylethers (PBDEs), tobacco smoke, and polycyclic
aromatic hydrocarbons (PAHs)
▪ Age: The chances of developing cancer increase with age even though it can occur at any age.
A survey shows more than three out of five people who get cancer are over the age of 65, and
more than a third are over 757.
▪ Lifestyle: Some of the choices in life such as excessive drinking and smoking increase the risk
of developing cancer.
▪ Nutrition: Diets of processed food and red meat are more likely to result in cancer than diets of
fruits and vegetables. Poor diets choices that often lead to obesity have been linked to breast,
womb, and kidney cancer.
▪Immune System: People with poor immune systems are found to have developed certain forms
of cancer like lymphomas.
▪Viruses and Bacteria: These microbes can cause the damages to the cell making them more
prone to cancer. Human Papilloma Virus (HPV) is linked with developing cancer on cervix, anal,
or genital area.
Prevention of Cancer
Decades of research revealed that cancer is easier to prevent than to treat. There is not a
single factor that leads to cancer. There are multiple things in our genes, lifestyle, and the
peripheral environment that determine the risk of developing cancer. So, any step taken to
15

decrease the chances of developing cancer is called cancer prevention. The following measures
can be taken to reduce the risk of cancer: no use of tobacco, healthy diet, physical activities to
keep a healthy weight, less exposure to sun, immunization against viruses and bacteria, safe
health practices, and regular medical checkup.
Treatment of Cancer
There options for cancer treatment is not limited to single rather a range of options are
available. The best option is determined by various factors like age, history, and lifestyle. More
often various types of treatment are combined to get the best possible result. The most popular
types of cancer treatment are discussed below.
Surgery
Surgery is a common and oldest technique to treat or even help prevent cancer. The first
use of this technique was employed by ancient Egyptians to remove breast tumors in 7th century.
If the cancer is benign, it offers the biggest chance for cure as the tumor does not get a chance to
spread around the body. However, if the cancer has metastasized, surgery won’t be very
beneficial. Some type of surgery is usually performed in most people with cancer. The
symptoms of bowel obstruction or spinal cord compression can be controlled by surgery9.
Chemotherapy
Chemotherapy is the use of chemicals to kill the cancer cells or stop them from growing.
The chemicals interferes the process of cell division by either damaging the RNA or DNA.
Chemotherapy is primarily used to damage the DNA of the affected cancer cells, stop the cell
from replicating by inhibiting by inhibiting the synthesis of new DNA strand, and stop the
division of original cell into its daughter cells in mitotic phase of cell division. The drugs for
chemotherapy are given in combination of two or three at the same time. These combinations are
16

called regimens. The purpose of regimens differs according to the stage of cancer. For instance,
regimens lower the risk of cancer coming back in early stage breast cancer, while it makes
cancer shrink or disappear in advanced stage. Chemo therapy not only kills the cancer cells but
affects the healthy cells. Damage in the blood cells results in anemia, fatigue, and various kinds
of infections. Mouth sores and diarrhea are caused by the damage in the cell at mucous
membrane. Another common side effect of chemo therapy is the destruction of cells at hair roots
and follicles that ultimately results in loss of hair. The cytotoxic chemotherapy drugs have
different method of killing cancer cells. They are classified accordingly to following classes:
alkylating agents, heavy metals, antimetabolites, anthracycline, antibiotics, epipodophyllotoxins,
plant alkaloids, and antitumor antibiotics.
Radiation Therapy
In radiation therapy, high energy particles are used to damage the cancerous cells in the
body. The common types of radiation used are X-rays, gamma rays, and charged particles. If the
radiation is delivered by a machine outside the body, it is known as external-beam radiation
therapy and if the radiation is delivered from radioactive material placed inside the body near
cancer calls, it is called brachytherapy or internal radiation therapy. The radiation either damages
DNA directly or it creates free radicals inside the cell that actually end up damaging the DNA.
Once the DNA is damaged, cancer cells stop dividing and eventually die and will be eliminated
by body’s natural processes.
Targeted Therapy
Targeted therapy is a selective way of attacking the cancer cells with drugs or other
substances. It is a newer type of treatment and is precise and does very little damage to normal
cells. It interferes with the proliferation and spread of cancer cells. This form of therapy mainly
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focus on proteins that are involved in cell signaling pathways regulating the basic cellular
functions and activities like cell division, cell movement, cell responses, and cell death. When
the signals to divide and grow uncontrollably are blocked, the progression of cancer is halted and
may even induce death of the cancer cell through a process called apoptosis. Small-molecule
drugs or monoclonal antibodies are the most common targeted therapies. It is convenient for
small-molecule drugs to diffuse into the cell to act on the specific targets. Monoclonal antibodies
are directed against the targets outside the cell because they cannot penetrate the plasma
membrane. In case of chronic myeloid leukemia (CML), BCR-ABL gene is responsible to relay
the signal regulating cell proliferation. Continuous proliferation of CML cells can be controlled
by targeting BCR-ABL using targeted therapy. In contrast to traditional chemotherapy, targeted
therapies are generally better tolerated, but they are associated with several adverse effects, such
as acneiform rash, cardiac dysfunction, thrombosis, hypertension, and proteinuria10.
Immunotherapy
Immunotherapy is a new type of therapy to fight against various types of cancers where
body uses own immune system to help fight cancer. The immune system is a group of cells and
organs that work together to defend the body against foreign particles such as cancer cells,
bacteria, and viruses. The defense mechanism is known as immune response where several kinds
of cells like macrophages, lymphocytes, T lymphocytes, dendritic cells, and granulocytes go into
action after the entry of foreign particles. These immune cells communicate with each other by a
number of special protein molecules known as cytokines. Cytokines can be natural, recombinant,
or synthetic. Some of the cytokines are interferons, interleukins, tumor necrosis, and colonystimulating factors6-8. The idea of immunotherapy treatment involves giving larger amounts of
proteins either by an injection or infusion so that the cells of immune system acts more
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effectively to make tumor cells more prominent to the immune system. The active agents of
immunotherapy are termed as immunomodulators. Flu, chills, fever, nausea, fatigue, and loss of
appetite are some of the common side effects of this type of therapy.
Hyperthermia
Hyperthermia is a type of cancer treatment in which the temperature of tumor-loaded
tissue is raised up to 113°F. The applied high temperature is capable of killing the cancer cells
with minimal injury to normal cells. It is applied as an adjoining therapy with other established
cancer treatments like radiotherapy and chemotherapy. With the use of this form of treatment,
cancer cells becomes more sensitive to radiation that otherwise would resist radiation. Heat is
applied by using microwave, radiofrequency, and ultrasound to a small specific area such as
tumor in the case of local hyperthermia. Metastatic cancer that has spread throughout body is
treated by using whole-body hyperthermia by raising the body temperature to 107-108°F using
thermal chambers 11.
Antioxidants
In general sense, any substances that slow down or prevent the oxidation of other
compounds are known as antioxidants. Chemically, antioxidants are compounds that have
capability to act as an electron donor. This property is particularly important as they can stabilize
or deactivate free radicals. A free radical is a species that contains one or more unpaired
electrons and are electron-deficient. These are very reactive as they have unsatisfied electron
valence pair and can be produced in both normal and pathological processes. Free radical
represents reactive oxygen species (ROS) such as hydroxyl radical, the superoxide anion radical,
hydrogen peroxide, nitric oxide radical, singlet oxygen, and various lipid peroxides. All of these
species are capable to react with membrane lipids, nucleic acids, proteins, and enzymes resulting
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in cellular damage. Aging, atherosclerosis, cancer, pulmonary dysfunction, Parkinson’s disease,
renal diseases, and neonatal lipoprotein oxidation are some of the effects of reactions initiated by
free radicals. There are numerous pathways for the generation of ROS inside the body but
following are the common ones.
▪ Result of normal aerobic metabolism: Most of the oxygen in the human body gets
consumed by the mitochondrial electron chain transport but some manage to escape to
form free radicals.
▪ Consequence of oxidative burst from phagocytes in the process of defense mechanism
against foreign particles including bacteria and viruses.
▪Product of xenobiotic metabolism, detoxification, of toxic substances
Antioxidants terminate the chain reactions by removing free radical intermediate and
inhibit other oxidation reactions. They do this by being oxidized themselves, so antioxidants are
often reducing agents such as thiols, ascorbic acid, or polyphenols.
R●

+ AH → RH

+ A●

RO● + AH → ROH + A●
ROO● + AH → ROOH + A●
R●

+

A●

→ RA

RO●

+

A●

→ ROA

ROO● +

A●

→ ROOA

Antioxidant + O2 → Oxidized Antioxidant
Scheme 1. Reaction of Oxidants with Radicals
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There are two kinds of antioxidants: Natural and Synthetic antioxidants. The examples of
natural antioxidants are tocopherols, nordihydroguaretic acid (NDGA), sesamol, and gossypol.
Some of the synthetic antioxidants are butylated hydroxyl anisole (BHA), butylated hydroxyl
toluene (BHT), propyl gallate (PG), and tertiary butyl hydroquinone (TBHQ).Most of the
antioxidants currently in use are monohydroxy or polyhydroxy phenol compounds with different
ring substituents. They have low activation energy to donate hydrogen and the resulting
antioxidant free radical does not initiate another free radical due to the delocalization of radical
electron as shown in Scheme 2. The resulting antioxidant free radical is quite stable so does not
undergo rapid oxidation.

Scheme 2. Stable Resonance Form of BHA
Natural Compounds with Health Benefits
The search for possible therapeutic drugs for cancer is ongoing on natural sources like
plants, animals, marine organism, or microorganism. A recent report indicates that medicinal
plants are used by 80% of people living in the rural areas of developing countries where the
primary health care is inadequate14. Plants have always been used as sources of medicinal agents

21

since the beginning of mankind. The chemical and biological diversity found in nature has
always been an indispensable resource for the development of novel anti-cancer compounds. The
quest has been assisted by the improvement in technology like structure elucidation and organic
synthesis. It is estimated that about 100 natural products have been included in treatment of
various forms of tumor during the last five decades of research 13. Plant derived anticancer agents
represents just about one-fourth of the total treatment options at present. In US, nine compounds
originating from plants have been approved for use in cancer therapy since 1961. The agents are
vinblastine, vincristine, navelbine, etoposide, teniposide, taxol, taxotere, topotecan, and
irinotecan. Another 11 agents are 10-hydroxycamptothecin, (-)-sophocarpine, monocrotaline, dtetrandrine, lycobetaine, indirubin, colchicinamide, curcumol, curdione, gossypol, and
homoharringtonine. For instance, vinblastine and vincristine, natural alkaloids found in
Catharanthusroseus or Vincarosea, are used as drugs in the treatment of lymphoma and leukemia
respectively. It has been found different plants contain different bioactive compounds that
depend on the area, climate, and the mode of agriculture. The main challenge for the anti-cancer
drug is the re-establishment of apoptosis and some plant products have been found to induce
apoptosis. A significant progress has made using this particular capability of plant products.
Vinca alkaloids that were isolated from Catharanthusroseus is an example of successful
anticancer plant product. These compounds bind to tubulin and disrupt the mitotic assembly in
course of cell division15. Another example is taxol, an extract from the bark of Taxusbrevifolia. It
has the cytotoxic capability that is mediated by the stabilization of microtubules16.
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Polyphenols and Its Classification
Compounds that have more than one phenolic hydroxyl group attached to one or more
benzene rings are known as polyphenol as shown in Fig 1. It is one of the most numerous and
ubiquitous group of plant metabolites that can range from a simple phenolic molecule to highly
polymerized compounds. The interests in polyphenols have recently surged because of the anticancer properties. The anti- cancer properties of polyphenols can be attributed to their ability to
act as anti-oxidants, and also to their ability to interact with basic cellular mechanisms. Free
radical scavenging and metal chelating are the modes of action to act as an antioxidant. The
chain-breaking ability of polyphenols is attributed to the ease of donation of the phenolic H-atom
to the attacking free radical. Fruits and vegetables are rich sources of polyphenols so the regular
consumption of food with polyphenols significantly reduces the risk of various types of cancer.
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Fig 1. Classification of Polyphenols
Flavanoids as Anti-Cancer Compounds
Another class of natural compounds that show anti-cancer activity is flavanoids. The
structure is shown in Fig 2. It is abundantly found in plants and vegetables and has been linked
to reducing the risk of chronic diseases including cancer. At least 4000 distinct types have been
found. Many flavonoids are found to have antioxidative activity, free-radical scavenging
capacity, and coronary heart disease prevention along with anti-cancer activity. It is categorized
as a chemo preventive substance that has been found to either delay or reverse the process of
carcinogenesis. The mechanism involved during the course of action may be divided as blocking
effects and suppressing effects. Flavanoids can regulate P-glycoprotein (Pgp), the MDR
(multidrug-resistance) protein that plays a major role in overcoming the major hurdle, drug
resistance17. Flavanoids have a major role in inhibiting various enzymes that are the targets in
anticancer treatment, e.g. eukaryotic DNA topoisomerase I, Cox I and II, and estrogen 2- and 4hydroxylases18.

Fig 2. Flavone Structure
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Anthraquinonesand Napthaquinonesas Anti- Cancer Compounds
Anthraquinone is a class of aromatic organic compound that contains two keto groups on
the central ring as shown in Fig 3. Aloe emodin is one of the anthraquinones which inhibits cell
growth in tumor of lung carcinoma, hepatoma, and leukemia. Aloe emodin particularly plays an
important role in the regulation of cell-cycle progression and shows a high specificity for
neuroectodermal tumor cells. Other anthraquinones like emodin and rhein were liked with G1/S
cell-cycle arrest in hepatoma, glioma, and colon carcinoma cells19.
Napthaquinone usually refers to organic compound derived from naphthalene. Juglone is
the most studied napthaquinone known for its anti-bacterial, anti-fungal, and anti-viral
properties. Its ability to induce apoptosis in the tumor cell marks juglone as an anti-cancer
compound.

Fig 3. Structures of Anthraquinones and Napthaquinones
Stilbene
The name stilbene was derived from a Greek word stilbos, which means shining. Stilbene
is a highly conjugated compound and named 1, 2-diphenylethylene. There are two isomeric
forms of stilbene shown in Fig 4: (E)-stilbene also known as trans-stilbene and (Z)-stilbene also
known as cis-stilbene. The sterical interaction of phenyl rings forces them out of plane and
prevents conjugation making the cis isomer thermodynamically less stable. (E)-stilbene has a
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melting point of 125°C, while the melting point of Z isomer is around 6°C20. Under the exposure
to light, trans-stilbene can isomerizes to cis-stilbene using the features associated with absorption
and fluorescent properties. During the process, the excitation of π- electrons of the conjugated
ethenediyl group occurs to π* orbitals. Thus, excited singlet state is governed by fluorescence
from the S1state competing with isomerization. The process of photochromism, transcisphotoisomerization of stilbene derivatives, can be observed easily by a single steady-state
fluorescence technique20.

Fig 4. Structure of Cis and Trans Stilbene
Derivatives of Stilbene
Synthesis of stilbene derivative is fairly simple as the derivatives are usually thermally
and chemically stable. They exhibit absorption and fluorescence properties that can be monitored
by various optical techniques. The derivatives of stilbene are primarily used for various
industrial, photophysical, photo chemical, and biomedical research purposes. Stilbenoids,
hydroxylated derivatives of stilbene, are the secondary products of heartwood formation of trees
that can also act as phytoalexins21.
Pterostilbene
Researchers have found that pterostilbene (Fig 5) and resveratrol works in a synergistic
fashion for various beneficial functions in the human body. For example, both the compounds
activate one’s “longevity genes” and pterostilbene assists in gene expression in a way that
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increases the effects produced by resveratrol21-23. Rimando and researchers at University of
Illinois at Chicago made a huge discovery in 2002 about the anti-cancer properties after the tests
in rats’ mammary glands22.

Fig 5. Structure of Pterostilbene
Piceatannol
Piceatannol is a naturally occurring hydroxylated analogue of resveratrol that shows wide
spectrum of biological activity (Fig 6). Piceatannol has been found in grapes, passion fruit, white
tea, and Japanese knotweed and has antioxidative and anticancer properties. In addition,
piceatannol is found to be involved in the suppression of the activation of some transcription
factors like NF-kappaB that plays a major role as a transcriptional regulator in response to the
cellular stress caused by free radicals, UV radiation, cytokines and microbes24.Piceatannol has
been found to either delay or inhibit the process of adipogenesis indicating its use against
obesity25, 26.

Fig 6. Structure of Piceatannol
27

Pinosylvin
Pinosylvin is another hydroxyl stilbene that lacks a hydroxyl group on the second ring as
shown in Fig 7. The absence is accounted by its origin as a product of condensation of malonylCoA and cinnamoyl-CoA instead of p-coumaroyl CoA. Unlike phytoalexins, pinosylvinis
produced before the infection and are called pre-infectious stilbenoid. Pinosylvin is found in
thePinusspecies.Pinosylvin has been found to exhibit anti-apoptotic effect27and a suitable
candidate to act as a pro-angiogenic factor27.

Fig 7. Structure of Pinsosylvin
Resveratrol
Resveratrol is a naturally occurring phytoalexin produced by plants in response to stress,
UV radiation, and fungal attack. RV is found in grapes, wine, peanuts, blueberries, cranberries,
mulberries, and jack fruit. RV has also been found in seeds, roots, vines, and stalk but the highest
concentration is found on the skin which is 50-100 µg per gram. It is interesting to note that on
average around 73 µg of RV in found in peanuts while 160 µg on an ounce of red wine. RV was
first discovered in 1940 as an off-white powder from the extract of roots of white hellebore lily
(Veratumgrandiflorum). It was considered a resorcinol (Fig 8) derivative coming from a veratum
species so was named resveratrol. Dried roots of white hellebore and Japanese knotweed
(Polygonumcuspidatum) were found to have RV and were used to treat various skin infections
like athlete’s foot.
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Fig 8. Structure of Resorcinol
Nomenclature
According to IUPAC nomenclature, RV is named as trans-3, 4’, 5-trihydroxystilbene (Fig
9). The structural formula and numbering of carbon is shown below. Some other names used for
RV are 3, 4’, 5-Stilbenetriol, (E)-5-(p-Hydroxystyryl) resorcinol and (E)-5-(4-hydroxystyryl)
benzene-1, 3-diol.

Fig 9. Structural Formula of RV
France has one of the lowest rates of cardiovascular disease (CVD) rates in the world31.
According to a report by World Health Organization 2009 Mortality Database, the deaths from
cardiovascular disease (CVD) for French population were 50 out of every 100,000, while it was
129 for American counterparts31. It was really surprising to see the low rates despite the intake
of high cholesterol and saturated fats in French diet. It led to a phenomenon known as French
Paradox that attributes the lower incidence of coronary diseases for regular consumption of red
wine, a major source of RV. The term “French Paradox” was first coined by Serge Renaud in

29

1993 in an effort to explain the low rates of CVD in France on the basis of red wine
consumption31, 32.
Chemical and Physical Properties
RV exists as white powder with slight yellow cast in two geometric isomers (Fig 10): cis
(Z) or trans (E). The Z isomer is sterically hindered and less stable because the steric interactions
forces the aromatic rings out of plane and prevent conjugation.The trans form can isomerize to
give cis-form in presence of UV radiation by a process called photo isomerization.

Fig 10: Structure of Cis-RV and Trans-RV
RV is a fat soluble compound and has very limited solubility in water. The solubility of
RV in water is 0.03g/L while the solubility in ethanol and DMSO are 50g/L and 16g/L
respectively. RV behaves in a similar manner to phenol when reacting with other
chemical species as it a polyphenol. The stilbene skeleton is stable and the reactivity is
associated with the hydroxyl functional group of phenol units. RV is a good radical
scavenger through electron capture or proton donation to convert free radicals to more
stable molecules. The hydroxyl group at 3 and 5-position (Fig 10) are equivalent because
of the rotation of the sigma bond between carbon-1 and SP2 hybridized carbon. The
hydroxyl group at 4’-position (para) is more acidic than the ones at 3 and 5-position
(meta). This is accounted by the stabilizing effect caused by the delocalization of
electrons over a greater area resulting in more resonance structures. The formation
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resonance structure for para and meta hydrogen abstraction is shown below in Scheme 3
and Scheme 4 respectively.

Scheme 3. Resonance Structures from Proton Abstraction at Para Position50

Scheme 4. Resonance Structures from Proton Abstraction at Meta Position50.

Biological Activities
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RV has been reported to exhibit a wide range of biological and pharmacological
properties that are beneficial for human health like anti-inflammatory33-35, antioxidant33-36,
antiproliferative34, proapoptotic33, antiaging34, cardioprotective33-36, anticancer33-36,
neuroprotective34, 35 , and antiviral properties33-36. It has also been speculated RV can promote
nitric oxide production33-36, inhibit platelet aggregation33-36 , and increase high-density
lipoprotein cholesterol to serve as a cardioprotective agent33-36. Recently, RV has been identifies
as a sirtuin-activating compound33. Sirtuins are a conserved family of NAD+-dependent
deacetylases (class III histone deacetylases). Like SIRT1, small-molecule activators of sirtuins
including resveratrol extend lifespan in yeast and higher organisms33. It has also been reported
RV has potential inhibitory effects on cyclooxygenase36, rat liver mitochondrial ATPase36,
human F1 ATP-ase36, and tyrosinase36. It has been that there is a close relationship between the
process of aging and the onset of neurological disorders so an ideal compound to fight against
the neurological disorder should have neuroprotective action and anti-aging effect. RV has both
the properties and is a suitable candidate for the treatment of neurological disorders like
Parkinson’s and Alzheimer’s39. According to European Journal of Pharmacology, RV has
important anti-inflammatory neuroprotective effects on animal models with Parkinson’s disease.
RV has been found to have a capability to prevent “free-radical-mediated damage of nerve cells”
39 that further assists in overcoming the damage caused by deep brain stimulation39.
Resveratrol as a Cancer Drug
Hundreds of plant extracts were evaluated to find chemical agents that inhibit cancer.
Resveratrol was discovered as a result of search for chemo preventive agents37.
Chemoprevention is the prevention of cancer by administering chemical agents that reduce the
risk of carcinogenesis. Some of the examples of agents are nonsteroidal anti-inflammatory drugs
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(NSAIDS) that include indomethacin, aspirin, piroxicam, and sulindac37, 38. The primary function
of these agents is to inhibit cyclooxygenase (COX) 37. This inhibition is significant in course of
chemoprevention as COX catalyzes the substances that induce tumor growth and suppress
immune surveillance. RV is currently in clinical phase II trial as an anti-cancer drug for the cure
of human colon cancer36. In mice RV has been found to selectively suppress the transcriptional
activation of acytochrome P-450 1A1 that further inhibits the formation of carcinogen-induced
preneoplastic lesions. Some compounds turn into carcinogenic after they have been metabolized
by enzymes like cytochrome P450. RV actually inhibits the function of certain cytochrome P450
which would be instrumental in reducing the exposure to the activated carcinogens. RV also
stimulates apoptosis, cell cycle delay or a block in G1→S1 transition phase at cellular level38.RV
has been found not only to inhibit the proliferation of cancer cells but also induce apoptosis in
various cancer cell lines. Another significant role played by RV against cancer is the inhibition
of metalloproteinase, an enzyme that helps the cancerous cells to invade normal tissue.
Pharmokinetics of Resveratrol
In spite of the therapeutic effects, pharmacokinetic properties of RV are not favorable.
This is mainly because of poor bioavailability and rapid metabolization to glucuronide and
sulfate conjugates. The plasma concentration of RV after the oral administration was found to be
very low. In a study, RV was administered orally for 14 consecutive days at 50 or 150 mg/kg/day
and plasma concentrations of RV and metabolites were measured using HPLC mass
spectrometer system40. RV was found to be approximately 20 percent bioavailable41. In rodents,
RV was found to be absorbed mainly in duodenum and has the same 20 percent bioavailability40.
Majority of the absorbed RV was found in plasma as conjugated derivatives. The five distinct
metabolites found were RV monosulfate, two isomeric forms of RV monoglucuronide,
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dihydroresveratrolmonosulphate and dihydroresveratrol monoglucuronide40, 41. The modification
into the glucuronide and sulphate reduces the permeability and helps in excretion that has been
found to reduce the bioavailability of RV. To enhance the pharmacokinetics, drug delivery
systems need to be developed to protect and stabilize resveratrol and to enhance its
bioavailability. Another method could be the administration of resveratrol through buccal cavity.
Biological Synthesis of Resveratrol
As discussed earlier, RV is produced as a phytoalexin by plants as a defense against
pathogen attack. RV is synthesized from p-coumaroyl-CoA and three molecules of malonylCoA. Stilbene synthase is used as enzyme during the course of reaction and is not very specific
because it has also capability to accept other CoA esters and aliphatic primers for polypeptide
synthesis. The stilbene synthase is a condensing enzyme that uses three sequential condensation
reactions with malonyl-CoA. The terminal carboxyl group is lost towards the end of the reaction
as carbon dioxide. Chalcone is also synthesized in a similar fashion but uses different enzyme
called chalcone synthase. The process is shown on Scheme 5 below.
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Scheme 5. Biosynthesis of Resveratrol
Chemical Synthesis of Resveratrol
It may not be quite feasible and economical to extract resveratrol from the natural sources
all the time so various efforts have been made to synthesize in the laboratory. Some of the
popular methods with a good yield are depicted below with reaction Scheme 6 and Scheme 7.

Scheme 6.Synthesis of RV Using Sequential Heck Reaction
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Scheme 7. Resveratrol Synthesis by Mingfu Wang et al46.
Derivatives of Resveratrol
Various attempts have been made to synthesize new derivatives of RV to improve its
biological activities. Structure-activity is used to analyze information of various properties like
anti-tumor by selective modification of stilbene scaffold of resveratrol. The substitution of
hydroxyl groups of RV by methoxy groups has been found to significantly improve the cytotoxic
activity. Various methoxylated analogs of RV have been made since and some of the examples
are shown below in Fig 11. Tetramethoxy-trans-stilbene was found to be more powerful in
inhibiting the growth of cancer cell lines like colon, prostate, and ovarian cancer cells33.
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Fig 11.Methoxylated Derivatives of Resveratrol
Compounds formed by the introduction of hydroxyl groups in stilbene have shown more
biological activities than RV. Both tetrahydroxy-trans-stilbene and hexahydroxy-trans-stilbene
has been found to inhibit cell growth and induce apoptosis in higher extent than RV33, 47. They
have also been found to cause cell-cycle arrest at S or G2/M-phase. Some of the hydroxyl
derivatives of RV are shown below47, 48 in Fig 12.

Fig 12.Hydroxylated Derivatives of Resveratrol
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Acetylated derivatives of RV were found to enhance cellular uptake than the parent
compound, RV. For example, resveratrol triacetate was found to be efficient in inducing cellcycle arrest at S-phase and increases uracil mediated inhibition of proliferation. Another ester
derivative, digalloylresveratrol, was found to induce apoptosis and inhibit the transition from S
to G2/M-phase of the cell cycle47, 48. It also helped in the inhibition of the growth of colon cancer
cells48. Some of the acetylated derivatives are shown below in Fig 13.

Fig 13. Miscellaneous Derivatives of Resveratrol
In 2008, Jiang synthesized two RV aliphatic acids and their esters in an attempt to
overcome the limitations of RV. The derivatives showed better solubility in pure water and
phosphate buffer (pH 7)36. The binding affinity of new derivatives with human serum albumin
was 41-fold improvement and was much better ligand36. The derivatives are shown in Fig 14.
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Fig 14.Derivatives of RV by Jiang
Drawbacks of RV
RV has been reported to have a lot of benefits to human health but the in vivo biological
effects are strongly reduced by its low bioavailability and solubility. Its bioavailability is very
limited due to high metabolization when subjected in plasma. This is a hurdle to the development
of possible therapeutic applications. Most of the research is done in cultured cells that are
exposed to unmetabolized RV and are of higher concentration than the one in blood plasma so it
is also not quite sure if RV reaches the proposed site of action when administered orally. A study
was conducted by giving a 25 mg oral dose RV to six healthy human but a trace amounts of
unchanged resveratrol (<5 ng/mL) was detected in plasma. Most of the oral dose was recovered
in urine as metabolites42-45.
Objective of this Research
The main objective of this research was to synthesize new derivatives of RV to overcome
its drawbacks i.e. low solubility and low bioavailability. The new derivatives are expected to
show anti-cancer properties and thus be able to use as chemo preventive compounds. The initial
plan was to synthesize triester derivatives and hydrolyze to form diester derivatives. However,
the aim was changed and limited to the synthesis of triesters. Also, another purpose of the
research was to carry out independent organic synthesis and structure elucidation of new
derivatives by spectral analysis.
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Synthetic Design
The objective of the research was inspired by the derivatives reported by Jiang 36. Jiang
reported the synthesis of new RV aliphatic acids and esters that was found to be much better
ligand for human serum albumin than RV36. The design for this research was to add both
aliphatic and aromatic chain in all hydroxyl groups through an esterification reaction resulting
triesters and is shown in Scheme 8.

Scheme 8.Synthesis of Resveratrol Triester by Esterification
The proposed synthetic pathways for the compounds 1, 2, and 3 have been shown below
respectively in Scheme 9, Scheme 11, and Scheme 12. Scheme 10 shows the reaction mechanism
involved.
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Proposed Synthetic Pathway for Synthesis of 3, 4’, 5-tri ( benzoyloxy) stilbene

Scheme9: Synthesis of 3, 4’, 5- (benzoyloxy)stilbene

Scheme 10. Mechanism of Esterification of Resveratrol
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Proposed Synthetic Pathway for Synthesis of 3, 4’, 5- tri (toluyloxy) stilbene

Scheme 11: Synthesis of 3, 4’, 5- tri(toluyloxy)stilbene
Proposed Synthetic Pathway for Synthesis of 3, 4’, 5- tri (2”- butenoyloxy) Stilbene

Scheme 12: Synthesis of 3, 4’, 5 –tri (2”-butenoyloxy) Stilbene
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CHAPTER 2
RESULTS AND DISCUSSION
Synthesis of 3, 4’, 5- tri (benzoyloxy) stilbene

A high yield of approximately 90% of compound 1was obtained as white solid after the
purification using gradient column chromatography. The melting point of the compound 1was
found to be 158.2°C - 160°C and the Rf value was 0.65. The compound has not been synthesized
before and can be subjected for further biological evaluation or can be used as a precursor to
make diesters. Triethyl amine (TEA) was used as a base that also acts as a nucelophile to attack
the carbonyl carbon of benzoyl chloride. This resulted in the formation of a salt that acted as an
electrophile to attack the hydroxyl group in RV. The hydroxyl group at para position (4’) got
attacked because of acidity as shown in scheme 2. During the course of reaction, hydrogen
chloride was produced that was removed by the reaction with TEA forming a salt,
triethylammonium chloride. Removal of hydrogen chloride was essential for the reaction to
proceed further. The integration of peaks in NMR spectrum was carried out on the basis of
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aromatic hydrogen versus non- aromatic hydrogen. The ratio of aromatic to non-aromatic
hydrogen was 22:2 that could be obtained by adding the integration values. The peaks on the
higher field were due to solvents and moisture. Attempts to dry the sample were made, but the
peaks were still present. There were all together 19 different carbons were confirmed by the 19
peaks at 13C spectrum. The IR spectrum was used to confirm the presence of carbonyl groups
between 1735- 1750 cm-1as indicated on the spectrum. There was no stretch to indicate the
presence of hydroxyl group around the region of 3200-3500 cm-1. All these results confirmed the
formation of triester which is compound 1.
Synthesis of 3, 4’, 5- tri (toluyloxy) stilbene

Compound 2was obtained as a white solid after the purification using gradient column
chromatography. The compound had a melting point of 156.5-157.2°C and Rfof 0.7. It is a
novel triester derivative of RV which can be used either to form diester by hydrolyzing the para
position substituent using a hydrolytic enzyme or it can be subjected for biological evaluation to
test its bioavailability. The NMR spectrum was integrated separately for aromatic and non44

aromatic hydrogen. The methyl H’s of toluyl group was made a reference by normalizing it and
integrating other hydrogen present in the compound. NMR spectrum still indicates the presence
of some impurities so 13C spectrum was not taken for this compound. The IR spectrum was used
just to confirm the introduction of ester group. There was no indication for any peaks for
hydroxyl group around 3200-3500 cm-1, which means the esterification reaction was carried out
successfully.
Synthesis of 3, 4’, 5- tri (2”-butenoyloxy) stilbene

Compound 3 was obtained as brown dense oil with a moderately high yield of around
75%. Repeated attempts to purify the compound using column chromatography with various
solvent systems were made but were not successful. The TLC indicated the presence of multiple
products. It was a possibility for the double bond in ester chain to have different configuration
(cis and trans) that led to multiple products with similar polarity causing difficulty in separation.
The crotonyl chloride used was a mixture of both cis and trans isomer. It was a novel derivative
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of resveratrol that could be subjected for biological evaluation after further purification. Even
though the NMR spectrum showed some impurities, most of peaks for the hydrogen were
accounted. There were three different kinds of hydrogen in the ester chain that is shown on the
1

H NMR spectrum. The farthest peak at the high field represents the hydrogens at methyl group

of the ester chain and then the alkene hydrogens. All the peaks are not accounted for, which
means there were some impurities. Various attempts to purify the compound were not successful.
As a result, the compound was not pure to the publishable standard. IR spectrum was used to
make sure the hydroxyl groups were converted to the ester group by the esterification reaction.
The three carbonyl groups are represented by the peaks at 1734 cm-1and there are not any peaks
corresponding to hydroxyl group. These entire spectrums confirmed the formation of compound
3and indicated some impurities.
Conclusions
The objectives of the research were fulfilled with the synthesis of new RV triester (1, 2,
& 3) derivatives. All of these compounds are the new derivatives of RV that has not been
synthesized before. As per the standards of Journal of America Chemical Society, compound 1 is
publishable while 2 and 3 are not pure enough. The initial goal was to synthesize diesters by
hydrolyzing the ester chain at para position, but the objective was changed during the course of
research. Chemical esterification of phenolic compound was the primary synthetic route that was
used during the course of research. With this route, there were formation of many side products
that cost time, energy, and chemicals for purification. Also, it was not easy to separate the
impurities, the case with compound 3. It is primarily because of unselective nature of reaction.
Various attempts were made to make the reaction selective and to increase yield. The purity of
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the product was confirmed using 1H and 13C NMR. The confirmation of introduction of carbonyl
group and the disappearance of hydroxyl group in the novel derivatives were confirmed by IR.
All the compounds are new so can be subjected to biological evaluation. A similar triester
derivative of RV has been synthesized and reported to have much better bioavailability than RV.
Various future works can be carried out on these new derivatives. As has been investigated
before49, similar compounds like 1, 2, & 3 have biological potential as anti-cancer agents with
increased solubility and bioavailability. Collaborations with Dr. Deling Yin have used RV
derivatives in the past to pursue pharmaceutical applications. It is anticipated that compound 1-3
will also be investigated along these lines49. The triester derivatives can be used as a precursor
for synthesizing new derivatives (Scheme 13).

Scheme 13. Future Reactions of the New Triester
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The enzymatic hydrolysis can be carried out using an enzyme lipase like C. Antarctica
that will selectively hydrolyze the ester group at 4’ position. This position is less sterically
hindered than the 3’ and 5’ position. The next step after the enzymatic hydrolysis can be the
conversion of alcohol group into a variety of functional groups through Mitsunobu reaction. Oye
Mitsunobu discovered the reaction that uses triphenylphosphine and an azodicarboxylate like
diethyl azodicarboxylate (DEAD). The reaction proceeds with inversion of configuration on the
alcohol carbon. The order of addition of reagents is crucial, typically the alcohol, acidic
nucleophile, triphenyl phosphine are dissolved in THF, then DEAD added slowly to the mixture
and stirred for about 12 h. Various acid and ester derivatives have shown increased biological
activities and better solubility so the prospects and potential of compounds 1, 2, &3 to make
other derivatives are huge.
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CHAPTER 3
EXPERIMENTAL

General Methods
All the reagents used during the course of the experiment except resveratrol (RV) and
crotonyl chloride were purchased from Sigma (St Louis, MO, USA) and used without further
purification. RV and crotonyl chloride were purchased from Tokyo Chemical Industry Co. Ltd
(Tokyo, Japan) and used as supplied. Proton (1H) and Carbon-13 (13C) NMR spectra were taken
from JOEL-NMR Eclipse spectrometer operating at 400 MHz and 100 MHz for proton and
carbon nuclei respectively. Chemical shifts were recorded as delta values in parts per million
(ppm) relative to TMS. The multiplicity of the signals was documented as: s, singlet; d, doublet;
m, multiplet. CDCl3 and CD3COCD3 were used as solvents for NMR unless otherwise stated.
The infrared spectrum was obtained using a Shimadzu FTIR Presctige-21. Silica gel for gravity
column filtration was used as a stationary phase, while different mixtures of solvents were used
as eluents to carry out the column chromatography. Thin Layer Chromatography (TLC) was
conducted with UV active silica gel plates using suitable solvent mixtures that were then viewed
under UV lamp using short wave. All mass measurements were taken using Ohaus Adventure
Pro AV114 scale unless otherwise stated. Melting points of the compounds were recorded using
Thermo Scientific 9100 instrument.
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Experimental Procedures
Synthesis of 3, 4’, 5-tri (benzoyloxy) stilbene, 1
In a 50 mL round bottom flask, resveratrol (0.73 g, 3.18 mmol) was dissolved in 20 mL
acetone. Benzoyl chloride (2.32 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol) were
added and the mixture was stirred for 48 hours under nitrogen. A TLC was done every 12 hours
to observe the progress of the reaction and to confirm the formation of minimal side products.
The mixture was acidified using 2N HCl (pH < 5). The resulting mixture was extracted by ethyl
acetate (2×25 mL), washed with saturated sodium bicarbonate solution (2×10mL) to removes
excess acid, and dried over anhydrous magnesium sulfate. The crude solution was concentrated
and purified by column chromatography (30:70 v/v, acetone:hexane). Compound 1{C35H25O6}
(1.55 g, 90%), M.P = 149.6 – 151°C, Rf value = 0.65 was obtained as white solid. 1H NMR (400
MHz, CDCl3, δ, ppm), 7.3 (d, 2H), 7-8.2 (m, 22H, Ar-H), 13C NMR (100 MHz, CDCl3,δ, ppm),
114.8, 117.2, 122.6, 127.9, 128.9, 129.3, 130, 130.2, 130.23, 130.5, 130.7, 134, 134.6, 135.5,
139.9, 151, 153.3, 164.9, 165.2. IR (cm-1) 1732.08 (C=O stretch), 1701.22, 1593.2, 1585.49,
1504.48, 1494.83.
Synthesis of 3,4’,5-tri(toluyloxy) Stilbene, 2
To a one-neck 50 mL round bottom flask were added resveratrol (0.7 g, 3.1 mmol),
acetone (20 mL), toluoyl chloride (2.64 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol).
The mixture was stirred at room temperature under nitrogen for 48 hours. A TLC was done
every 12 hours to check the progression of the reaction and the formation of products. The
mixture was acidified using 2N HCl (pH<5). A mixture was obtained that was extracted in the
organic layer by means of ethyl acetate (2× 20 mL) and washed with saturated sodium
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bicarbonate solution (2× 10mL) to remove excess acid. Anhydrous magnesium sulfate was used
to absorb the moisture and dry the product. Gravity filtration was used to remove the magnesium
salt from the solution. The reaction mixture was concentrated and purified using column
chromatography (40:60 v/v, acetone: hexane) to give compound 2 {C35H30O6} (1.430g, 79%).
M. P= 156.5-157.2°C. Rf value = 0.7 (Acetone/ Hexane, 30:70, V/V), 1H NMR (400 MHz,
CDCl3, δ, ppm), 7-8.2 (m, 19H, Ar-H), 7.5(d, 2H), 2.5 (s, 9H) IR (cm-1) 2922.16, 2877.79,
2852.72, 1735.93 (C=O stretch), 1714.72, 1693.5, 1683.86.

Synthesis of 3, 4’, 5-tri (2”-butenoyloxy) Stilbene, 3
To a one-neck 50 mL round bottom flask were added resveratrol (0.726 g, 3.18 mmol),
acetone (20 mL), crotonyl chloride (1.92 mL, 20 mmol), and triethyl amine (2.79 mL, 20 mmol).
The mixture was stirred under nitrogen atmosphere for 48 hours with TLC performed every 12
hours. A TLC was done to check the progression of reaction and to check the number of products
being formed during the course of the reaction. The mixture was acidified was using 2N HCl
keeping pH less than 5. Ethyl acetate (2× 20 mL) was used to extract the crude product that was
then washed with saturated sodium bicarbonate to remove any leftover acid. The organic layer
was dried using anhydrous magnesium sulfate. The magnesium salt was filtered using gravity
and purified with column chromatography (10-40% acetone to hexane in volume) to give
compound 3{C26H24O6} (1.04 g, 75%). Rf value = 0.60 (Acetone/ Hexane, 30:70, V/V), 1H
NMR (400 MHz, CDCl3, δ, ppm), 6.8-7.5 (stilbene, 9H), 6-6.1 (d, 2H, vinylic), 1.9 (s, 9H, CH3).
IR (cm-1) 2927.94, 2926.01, 1734.01 (C=O stretch), 1676.14, 1654.92, 1625.99, 1608.63,
1602.85, 1598.99, 1591.27.
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